$LMMY
LAMY

2024 Q3 Form 10-Q Financial Statement

#000168316824007084 Filed on October 11, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2023 Q3
Revenue $3.750K $0.00
YoY Change
Cost Of Revenue $0.00 $0.00
YoY Change
Gross Profit $3.750K $0.00
YoY Change
Gross Profit Margin 100.0%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.258K $1.258K
YoY Change 0.0% 0.0%
% of Gross Profit 33.55%
Operating Expenses $8.091K $12.16K
YoY Change -33.47%
Operating Profit -$4.341K -$12.16K
YoY Change -64.3% -6.24%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $431.00 $0.00
YoY Change
Pretax Income -$3.910K -$12.16K
YoY Change -67.85% -6.24%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$3.910K -$12.16K
YoY Change -67.85% -6.24%
Net Earnings / Revenue -104.27%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 7.777M shares 7.777M shares
Diluted Shares Outstanding 7.777M shares 7.777M shares

Balance Sheet

Concept 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $1.028K $1.318K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $15.25K
Other Receivables
Total Short-Term Assets $17.15K $1.318K
YoY Change 1200.83%
LONG-TERM ASSETS
Property, Plant & Equipment $3.693K $8.727K
YoY Change -57.68%
Goodwill
YoY Change
Intangibles $7.120K $16.79K
YoY Change -57.59%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $10.81K $25.51K
YoY Change -57.62%
TOTAL ASSETS
Total Short-Term Assets $17.15K $1.318K
Total Long-Term Assets $10.81K $25.51K
Total Assets $27.96K $26.83K
YoY Change 4.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $1.211K $1.145K
YoY Change 5.76%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $17.17K $4.145K
YoY Change 314.21%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $69.60K $63.94K
YoY Change 8.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.17K $4.145K
Total Long-Term Liabilities $69.60K $63.94K
Total Liabilities $86.76K $68.08K
YoY Change 27.44%
SHAREHOLDERS EQUITY
Retained Earnings -$87.08K -$69.52K
YoY Change 25.25%
Common Stock $778.00 $778.00
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$58.81K -$41.25K
YoY Change
Total Liabilities & Shareholders Equity $27.96K $26.83K
YoY Change 4.2%

Cashflow Statement

Concept 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$3.910K -$12.16K
YoY Change -67.85% -6.24%
Depreciation, Depletion And Amortization $1.258K $1.258K
YoY Change 0.0% 0.0%
Cash From Operating Activities -$1.416K -$7.951K
YoY Change -82.19% -14.47%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $1.416K $1.414K
YoY Change 0.14% 45.03%
NET CHANGE
Cash From Operating Activities -$1.416K -$7.951K
Cash From Investing Activities $0.00 $0.00
Cash From Financing Activities $1.416K $1.414K
Net Change In Cash $0.00 -$6.537K
YoY Change -100.0% -21.44%
FREE CASH FLOW
Cash From Operating Activities -$1.416K -$7.951K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12161 usd
CY2024Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
CY2024Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
CY2024Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001939937
CY2024Q3 dei Document Type
DocumentType
10-Q
CY2024Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q3 dei Document Period End Date
DocumentPeriodEndDate
2024-08-31
CY2024Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q3 dei Entity File Number
EntityFileNumber
000-56599
CY2024Q3 dei Entity Registrant Name
EntityRegistrantName
LAMY
CY2024Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
CY2024Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
37-2039216
CY2024Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
201 Allen Street
CY2024Q3 dei Entity Address Address Line2
EntityAddressAddressLine2
Unit 10104
CY2024Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
New York City
CY2024Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2024Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10002
CY2024Q3 dei City Area Code
CityAreaCode
657
CY2024Q3 dei Local Phone Number
LocalPhoneNumber
315-8312
CY2024Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024Q3 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2024Q3 dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7777000 shares
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1028 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1028 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15250 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11500 usd
CY2024Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
867 usd
CY2024Q2 us-gaap Interest Receivable Current
InterestReceivableCurrent
436 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
17145 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
12964 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7120 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9537 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3693 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4952 usd
CY2024Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
10813 usd
CY2024Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
14489 usd
CY2024Q3 us-gaap Assets
Assets
27958 usd
CY2024Q2 us-gaap Assets
Assets
27453 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1211 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1211 usd
CY2024Q3 LAMY Advances From Related Parties
AdvancesFromRelatedParties
15958 usd
CY2024Q2 LAMY Advances From Related Parties
AdvancesFromRelatedParties
12958 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
17169 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
14169 usd
CY2024Q3 LAMY Loans From Related Parties
LoansFromRelatedParties
18100 usd
CY2024Q2 LAMY Loans From Related Parties
LoansFromRelatedParties
18100 usd
CY2024Q3 LAMY Note Payable Related Party
NotePayableRelatedParty
10000 usd
CY2024Q2 LAMY Note Payable Related Party
NotePayableRelatedParty
10000 usd
CY2024Q3 us-gaap Other Notes Payable
OtherNotesPayable
29000 usd
CY2024Q2 us-gaap Other Notes Payable
OtherNotesPayable
29000 usd
CY2024Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
12495 usd
CY2024Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
11079 usd
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
69595 usd
CY2024Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
68179 usd
CY2024Q3 us-gaap Liabilities
Liabilities
86764 usd
CY2024Q2 us-gaap Liabilities
Liabilities
82348 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7777000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7777000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7777000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7777000 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
778 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
778 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
27492 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
27492 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-87075 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-83165 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-58805 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-54895 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27958 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27453 usd
CY2024Q3 us-gaap Revenues
Revenues
3750 usd
CY2023Q3 us-gaap Revenues
Revenues
0 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
3750 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
0 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8091 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
8091 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
12161 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
431 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3910 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12161 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-3910 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-12161 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7777000 shares
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7777000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7777000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7777000 shares
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-54895 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-3910 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-58805 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-29088 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-12161 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-41249 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-3910 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-12161 usd
CY2024Q3 us-gaap Depreciation
Depreciation
1258 usd
CY2023Q3 us-gaap Depreciation
Depreciation
1258 usd
CY2024Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2416 usd
CY2023Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2416 usd
CY2024Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
0 usd
CY2023Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
535 usd
CY2024Q3 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
4181 usd
CY2023Q3 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-0 usd
CY2024Q3 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
3000 usd
CY2023Q3 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
0 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1416 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7951 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2024Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2023Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2024Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2023Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2024Q3 LAMY Proceeds From Accrued Interest
ProceedsFromAccruedInterest
1416 usd
CY2023Q3 LAMY Proceeds From Accrued Interest
ProceedsFromAccruedInterest
1414 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1416 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1414 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6537 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1028 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7855 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1028 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1318 usd
CY2024Q3 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024Q3 LAMY Proceeds Of Loan From Related Party In Exchange Of Asset
ProceedsOfLoanFromRelatedPartyInExchangeOfAsset
0 usd
CY2023Q3 LAMY Proceeds Of Loan From Related Party In Exchange Of Asset
ProceedsOfLoanFromRelatedPartyInExchangeOfAsset
0 usd
CY2024Q3 LAMY Proceeds From Note Payable Against Acquisition Of Intangibles
ProceedsFromNotePayableAgainstAcquisitionOfIntangibles
0 usd
CY2023Q3 LAMY Proceeds From Note Payable Against Acquisition Of Intangibles
ProceedsFromNotePayableAgainstAcquisitionOfIntangibles
0 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-87075 usd
CY2024Q3 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_zuTn0m0aQEr9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Use of Estimates and Assumptions</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Due to the limited level of operations, the Company has not had to make material assumptions or estimates other than the assumption that the Company is a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2024Q3 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P3Y
CY2022Q2 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
15100 usd
CY2024Q3 us-gaap Depreciation
Depreciation
1258 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11406 usd
CY2022Q2 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
29000 usd
CY2024Q3 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P3Y
CY2024Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2416 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
21880 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7777000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7777000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7777000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7777000 shares
CY2024Q3 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-17465 usd
CY2024Q3 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
17465 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
17465 usd
CY2024Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
17465 usd
CY2024Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2024Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
84075 usd
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001683168-24-007084-index-headers.html Edgar Link pending
0001683168-24-007084-index.html Edgar Link pending
0001683168-24-007084.txt Edgar Link pending
0001683168-24-007084-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lamy-20240831.xsd Edgar Link pending
lamy_ex3101.htm Edgar Link pending
lamy_ex3102.htm Edgar Link pending
lamy_ex3201.htm Edgar Link pending
lamy_ex3202.htm Edgar Link pending
lamy_i10q-083124.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
lamy-20240831_cal.xml Edgar Link unprocessable
lamy-20240831_def.xml Edgar Link unprocessable
lamy_i10q-083124_htm.xml Edgar Link completed
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
lamy-20240831_lab.xml Edgar Link unprocessable
lamy-20240831_pre.xml Edgar Link unprocessable